
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) are trading lower Friday following approval of one of its treatments from the U.S.’s Food and Drug Administration.
SNDX shares are retreating from recent levels. Track the action here.

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) are trading lower Friday following approval of one of its treatments from the U.S.’s Food and Drug Administration.
SNDX shares are retreating from recent levels. Track the action here.